Forbes Medi-Tech Inc. Extends Contract With PharmaviteForbes Medi-Tech Inc. Extends Contract With Pharmavite
June 11, 2009
VANCOUVER, British Columbia—Forbes Medi-Tech Inc. extended its supply and licensing contract with Pharmavite LLC until mid 2010 for the continued sale of Reducol™, the branded cholesterol-lowering ingredient in one of Pharmavite's leading line of dietary supplements, Nature Made® CholestOff™ and CholestOff™ Complete™. The license is exclusive to Pharmavite LLC for distribution and sales in Food, Drug and Mass Merchandiser outlets.
"Since the initial product launch in 2001, the Nature Made CholestOff product line has grown significantly, establishing a strong position in the U.S. heart-health dietary supplement market," said Laura Wessman, senior vice president, operations at Forbes.
"We are pleased to maintain this relationship and anticipate that Pharmavite will continue to build awareness and sales of CholestOff products," Wessman added.
You May Also Like
Advancing gender equity in the nutraceutical industrySep 25, 2023
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Exercise recovery: Electrolytes, hydration and combating fatigue – SupplySide intensive webinarSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023